Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.

黄褐斑 医学 耐受性 色素沉着 皮肤病科 随机对照试验 不利影响 外科 内科学
作者
Elizabeth T Makino,James H Herndon,Monya L Sigler,Vincent P. Gotz,John A. Garruto,Rahul Mehta
出处
期刊:PubMed [National Institutes of Health]
卷期号:11 (12): 1478-1482 被引量:18
标识
摘要

There are numerous common skin disorders involving hyperpigmentation, including solar lentigines, postinflammatory hyperpigmentation, melasma, freckles, and dyschromia from photoaging. While these conditions are of an aesthetic nature, there is great interest in newer, safer, and more effective treatment modalities. Topical hydroquinone (HQ) has been the gold standard of skin lighteners for many years. However, regulatory authorities around the world are now questioning its safety. A randomized, double-blind, half-face study was conducted in females having moderate to severe facial hyperpigmentation to assess the efficacy and tolerability of 3 new skin brightener formulations containing SMA-432, a prostaglandin E2 inhibitor, compared with 4% HQ. Each subject was assigned 2 of the 4 test materials and was instructed to apply the product on the assigned side of the face twice daily for 12 weeks. Evaluation visits were conducted at baseline and at 4, 8, and 12 weeks. At each visit, subjects were evaluated by a blinded investigator for clinical efficacy and tolerability using grading scales. Standardized digital photography and Chroma Meter assessments were also taken. Self-assessment questionnaires were completed at weeks 4, 8, and 12. Sixty-eight Caucasian subjects (136 half faces) completed the study. All test materials significantly reduced overall hyperpigmentation and improved the Investigator's Global Hyperpigmentation Improvement rating at weeks 4, 8, and 12 compared with baseline. SMA-432 exhibited a dose-dependent improvement in hyperpigmentation. There were no major tolerability issues with any of the test materials. Self-assessments were generally favorable for all test materials. At the completion of the trial, subjects rated one of the tested multimodality brightener compositions as the most favorable product and 4% HQ as the least favorable. This study demonstrated that the new non-HQ-containing skin brightener formulations were as effective and equally well tolerated as the gold standard, 4% HQ, in females with facial hyperpigmentation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
忧伤的南莲完成签到,获得积分10
刚刚
111发布了新的文献求助10
刚刚
刚刚
是唐朝越啊完成签到,获得积分10
1秒前
LGL发布了新的文献求助10
1秒前
YAYING发布了新的文献求助10
3秒前
鹿饮溪发布了新的文献求助10
3秒前
王乐乐发布了新的文献求助10
4秒前
zhangyi完成签到 ,获得积分10
4秒前
占曼荷完成签到,获得积分20
4秒前
只只完成签到,获得积分10
4秒前
Taikonaut发布了新的文献求助10
4秒前
jiehe完成签到,获得积分10
5秒前
小蘑菇的应助被lqiu采纳,获得10
5秒前
水蜜桃完成签到,获得积分10
5秒前
无花果的应助被飞鸿影下采纳,获得10
6秒前
AXQ完成签到,获得积分10
8秒前
CDabin完成签到,获得积分10
8秒前
Jasper的应助被欣喜若魔采纳,获得20
8秒前
科研通AI6.2的应助被llll采纳,获得10
8秒前
椰妃完成签到,获得积分10
9秒前
传统的冷霜完成签到,获得积分10
10秒前
小西门完成签到,获得积分10
11秒前
研友_Z6Qrbn发布了新的文献求助10
12秒前
Eric的应助被少双采纳,获得10
12秒前
12秒前
李爱国的应助被哈斯u和采纳,获得10
13秒前
鹿饮溪完成签到,获得积分20
15秒前
15秒前
15秒前
汤包发布了新的文献求助10
16秒前
欣喜若魔完成签到,获得积分10
17秒前
18秒前
Jigsaw发布了新的文献求助10
18秒前
18秒前
想吃小面包完成签到 ,获得积分10
19秒前
脆脆炸香蕉完成签到,获得积分10
19秒前
CipherSage的应助被Irene采纳,获得10
19秒前
20秒前
欣喜若魔发布了新的文献求助20
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192078
求助须知:如何正确求助?哪些是违规求助? 9578698
关于积分的说明 21861559
捐赠科研通 7791583
什么是DOI,文献DOI怎么找? 3436814
关于科研通互助平台的介绍 2560538
邀请新用户注册赠送积分活动 2483582